ArticleBiochemistry and biophysics reports2019

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice.

Hiroyuki Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.